I’m heavily skewed to the company that has a chance to go 5x, 10x in the next 12-18 months off organic progress (could have one approved product in the US by end of this year and a second approved product in the US market by end of next year) .. with potential to go 20x or more if their blockbuster product hits the confirmatory phase 3 trial which is about to start recruiting.
there is always the chance of some M&A action, but I don’t invest based on that.
for IMU I am here to buy the dips over the next few years… and get a nice average. Still a long runway, and happy to pay more if clinical outcomes justify it.
I’m heavily skewed to the company that has a chance to go 5x,...
-
- There are more pages in this discussion • 2,662 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.4¢ | $417.0K | 9.281M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 6074903 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 362283 | 5 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |